🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, multi-center, 12-week, randomized, controlled, paral...
Status
Completed
Location
Please contact the Merck KGaA Communication Center
Start Date
2014-05-31
Trial ID
NCT02064816
The purpose of this trial is to examine the benefits of early combination o...
Status
Completed
Location
The Ohio State University Multiple Sclerosis Center
Start Date
2006-08
Trial ID
NCT00618527
Treatments Being Tested
This is an international multicenter study of tolerability, pharmacokinetic...
Status
Completed
Location
OOO "BioEk"
Start Date
2014-07
Trial ID
NCT02359877
The present study is a randomized clinical trial, with the approval of the ...
Status
Unknown
Location
Multiple Locations
Start Date
2020-08-20
Trial ID
NCT04521400
Treatments Being Tested
The purpose of this study is to find out if weekly Avonex works as well as ...
Status
Completed
Location
Research Site
Start Date
2002-08
Trial ID
NCT00599274
Treatments Being Tested
The primary objective was to determine the tolerability of a new inhaled fo...
Status
Completed
Location
Hammersmith Medicines Research
Start Date
2001-01
Trial ID
NCT01863069
Treatments Being Tested
The purpose of this study is to evaluate the change in patient-reported tre...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-05
Trial ID
NCT01317004
Treatments Being Tested
The study was to evaluate the efficacy and safety of evobrutinib administer...
Status
Terminated
Location
Please Contact U.S. Medical Information
Start Date
2019-08-26
Trial ID
NCT04032158
Treatments Being Tested
This was an open-label, multicentric, prospective, post-marketing surveilla...
Status
Completed
Location
Multiple Locations
Start Date
2005-07
Trial ID
NCT01142518
Treatments Being Tested
The aim of the study is to assess the safety of inhaled SNG001 and the abil...
Status
Completed
Location
Celerion
Start Date
2018-01-29
Trial ID
NCT03570359
Treatments Being Tested